Latest Asx Announcements News

Superior Resources Limited has lodged a transaction specific prospectus to offer 1,000 new shares at $0.01 each, enabling previously issued shares to be sold without further disclosure. The move addresses regulatory compliance while raising minimal funds.

Elixir Energy advances its dominant position in Queensland’s Taroom Trough with a major drilling campaign set for early 2026, aiming to address looming East Coast gas shortages. The company’s extensive acreage and certified resources position it as a key player in Australia’s energy future.

Sagalio Energy Limited has had its trading suspension lifted immediately following its response to an ASX Price Query, restoring market activity in its shares.

Clime Investment Management’s CIWO securities have been suspended from trading due to regulatory non-compliance, raising questions about the company’s next steps and investor impact.

DroneShield Limited has retracted its recent announcement of $7.6 million in new U.S. Government orders, clarifying these were reissued contracts rather than fresh deals. The company is addressing the administrative error to prevent future confusion.

Invex Therapeutics Ltd has had its trading suspension lifted following an announcement of new board and officer appointments, signaling a fresh chapter for the biotech company.

Chimeric Therapeutics has responded to ASX inquiries regarding the disclosure timing and materiality of new clinical data from its ADVENT-AML trial, emphasizing compliance with continuous disclosure rules and the careful verification of promising patient responses.

LCL Resources Limited faces suspension from ASX trading due to failure to lodge a required periodic report on time, raising questions about the company’s compliance and operational transparency.

Breakthrough Minerals Limited has resumed trading on the ASX following a pivotal announcement about a new mineral project acquisition and a capital raising initiative.

Anteris Technologies Global Corp. has had its trading suspension lifted following a key announcement about its capital raising plans, signaling renewed market activity.

Clarity Pharmaceuticals has responded to ASX queries clarifying the timing and materiality of its SAR-bisFAP data presentation, denying the information was price sensitive despite a notable share price rise.

Premier1 Lithium Limited’s PLCO securities have been suspended from trading due to regulatory non-compliance, raising questions about the company’s next steps and market impact.